Sequent Scien. Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Jun-2023	Mar-2023	Dec-2022	Sep-2022	Jun-2022
Gross Sales	333.21	366.67	375.31	337.61	341.32
Excise Duty	--	--	--	--	--
Net Sales	333.21	366.67	375.31	337.61	341.32
Other Operating Income	--	--	--	--	--
Other Income	0.79	1.74	2.86	0.91	0.88
Total Income	334	368.41	378.18	338.52	342.20
Total Expenditure	364.96	431.63	364.98	334.74	342.40
PBIDT	(30.95)	(63.23)	13.20	3.78	(0.20)
Interest	10.48	10.87	9.73	8.12	6.80
PBDT	(41.44)	(74.10)	3.48	(4.34)	(7)
Depreciation	14.24	14.71	13.67	13.38	13.93
Minority Interest Before NP	--	--	--	--	--
Tax	(11.70)	4.91	(0.40)	3.83	(0.05)
Deferred Tax	(9.30)	(1.27)	(0.02)	(17.11)	(5.57)
Reported Profit After Tax	(34.68)	(92.44)	(9.78)	(4.44)	(15.32)
Minority Interest After NP	0.17	1.14	(0.91)	(0.69)	(0.35)
Net Profit after Minority Interest	(34.85)	(93.57)	(8.87)	(3.75)	(14.97)
Extra-ordinary Items	(23.51)	(58.19)	--	--	(3.20)
Adjusted Profit After Extra-ordinary item	(11.34)	(35.38)	(8.87)	(3.75)	(11.77)
EPS (Unit Curr.)	(1.40)	(3.77)	(0.36)	(0.15)	(0.60)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	49.89	49.89	49.89	49.89	49.89
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	(9.29)	(17.24)	3.52	1.12	(0.06)
PBDTM(%)	(12.44)	(20.21)	0.93	(1.29)	(2.05)
PATM(%)	(10.41)	(25.21)	(2.61)	(1.31)	(4.49)

QuickLinks for Sequent Scientific Ltd.